• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过炎症产生的正反馈在HIV组织庇护所中产生双稳态行为。

Positive feedback through inflammation creates bistable behavior in HIV tissue sanctuaries.

作者信息

Jagarapu Aditya, Mann Rajveer, Piovoso Michael J, Zurakowski Ryan

机构信息

Department of Biomedical Engineering, University of Delaware, USA.

Department of Biological Sciences, University of Delaware, USA.

出版信息

Proc Am Control Conf. 2019 Jul;2019:3456-3461. doi: 10.23919/acc.2019.8815245. Epub 2019 Aug 29.

DOI:10.23919/acc.2019.8815245
PMID:32148339
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7060373/
Abstract

Combination Antiretroviral Therapy (cART) consists of a cocktail of drugs administered to HIV-infected patients that can suppress the amount of HIV in the patient's blood plasma to an undetectable level. Our previous work has suggested that some HIV-infected patients, despite being placed on cART, can still have ongoing viral replication occurring in self-sustaining inflamed lymph node follicle sanctuary sites. Spatial models of the putative sites show that inflammation is a necessary condition for ongoing HIV replication. In this study, we model the hypothesis that ongoing HIV replication may provide a sufficiently strong pro-inflammatory signal to maintain inflammation levels consistent with continued HIV replication. A system of ordinary differential equations integrated with a reactive-diffusion system is used to model the HIV dynamics and the diameter of a lymph node follicle as a function of time and external influence. The estimates of the parameters in our model come from prior data when available. The results of our study show that these dynamics have two stable steady-state solutions, one with low inflammation and no ongoing HIV replication in the site, and one with high inflammation and high levels of ongoing HIV replication in the site. We furthermore show that the system can transition between the two outcomes in response to a transient exogenous addition of pro-inflammatory signaling, consistent with the antigenic stimulus of a secondary infection. The spatial isolation of the sites results in a low viral load in the blood plasma for both conditions.

摘要

联合抗逆转录病毒疗法(cART)由多种药物混合而成,用于治疗HIV感染患者,可将患者血浆中的HIV数量抑制到检测不到的水平。我们之前的研究表明,一些HIV感染患者尽管接受了cART治疗,但在自我维持炎症的淋巴结滤泡庇护所部位仍可能存在持续的病毒复制。假定部位的空间模型显示,炎症是HIV持续复制的必要条件。在本研究中,我们建立了一个假设模型,即持续的HIV复制可能会提供足够强烈的促炎信号,以维持与HIV持续复制一致的炎症水平。使用一个常微分方程组与一个反应扩散系统相结合,来模拟HIV动态以及淋巴结滤泡直径随时间和外部影响的变化。我们模型中的参数估计值在有可用的先前数据时即取自这些数据。我们的研究结果表明,这些动态有两个稳定的稳态解,一个是炎症水平低且该部位无持续HIV复制,另一个是炎症水平高且该部位有高水平的持续HIV复制。我们还表明,该系统可以响应促炎信号的短暂外源添加而在两种结果之间转换,这与二次感染的抗原刺激一致。这些部位的空间隔离导致两种情况下血浆中的病毒载量都较低。

相似文献

1
Positive feedback through inflammation creates bistable behavior in HIV tissue sanctuaries.通过炎症产生的正反馈在HIV组织庇护所中产生双稳态行为。
Proc Am Control Conf. 2019 Jul;2019:3456-3461. doi: 10.23919/acc.2019.8815245. Epub 2019 Aug 29.
2
An Integrated Spatial Dynamics-Pharmacokinetic Model Explaining Poor Penetration of Anti-retroviral Drugs in Lymph Nodes.一种解释抗逆转录病毒药物在淋巴结中穿透性差的综合空间动力学-药代动力学模型。
Front Bioeng Biotechnol. 2020 Jun 26;8:667. doi: 10.3389/fbioe.2020.00667. eCollection 2020.
3
Ongoing HIV replication in lymph node sanctuary sites in treated individuals contributes to the total latent HIV at a very slow rate.在治疗个体的淋巴结避难所部位持续的 HIV 复制以非常缓慢的速度导致总潜伏 HIV 增加。
J Theor Biol. 2023 Nov 7;575:111651. doi: 10.1016/j.jtbi.2023.111651. Epub 2023 Oct 28.
4
Ongoing HIV replication in lymph node sanctuary sites in treated patients contributes to the total latent HIV at a very slow rate.在接受治疗的患者中,淋巴结庇护所部位持续的HIV复制以非常缓慢的速度促成了总的潜伏HIV。
bioRxiv. 2023 Feb 27:2023.02.18.529086. doi: 10.1101/2023.02.18.529086.
5
Increased inflammation in sanctuary sites may explain viral blips in HIV infection.免疫豁免部位炎症增加可能解释了HIV感染中的病毒波动。
IET Syst Biol. 2016 Aug;10(4):153-66. doi: 10.1049/iet-syb.2015.0066.
6
[Hurdles to HIV cure. Part 2 : ongoing HIV replication despite therapy].[攻克艾滋病的障碍。第2部分:尽管接受治疗但艾滋病病毒仍在持续复制]
Rev Med Liege. 2020 Sep;75(9):582-587.
7
HIV Maintains an Evolving and Dispersed Population in Multiple Tissues during Suppressive Combined Antiretroviral Therapy in Individuals with Cancer.在接受抑制性联合抗逆转录病毒疗法的癌症患者中,HIV在多个组织中维持着不断演变且分散的病毒群体。
J Virol. 2016 Sep 29;90(20):8984-93. doi: 10.1128/JVI.00684-16. Print 2016 Oct 15.
8
Predicted coreceptor usage at end-stage HIV disease in tissues derived from subjects on antiretroviral therapy with an undetectable plasma viral load.在接受抗逆转录病毒治疗且血浆病毒载量不可检测的受试者来源的组织中,对终末期HIV疾病时共受体使用情况的预测。
Infect Genet Evol. 2017 Jul;51:194-197. doi: 10.1016/j.meegid.2017.04.004. Epub 2017 Apr 6.
9
Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence.游离型 HIV-1 DNA 及其与 HIV-1 持续存在的其他标志物的关系。
Retrovirology. 2018 Jan 30;15(1):15. doi: 10.1186/s12977-018-0398-1.
10
HIV Controllers Have Low Inflammation Associated with a Strong HIV-Specific Immune Response in Blood.HIV 控制器的血液中炎症水平低,与强烈的 HIV 特异性免疫反应相关。
J Virol. 2019 May 1;93(10). doi: 10.1128/JVI.01690-18. Print 2019 May 15.

引用本文的文献

1
Designing a Predictive Model for Antiretroviral Regimen at the Antiretroviral Therapy Center in Chiro Hospital, Ethiopia.设计一个在埃塞俄比亚 Chiro 医院抗逆转录病毒治疗中心的抗逆转录病毒方案预测模型。
J Healthc Eng. 2021 Oct 29;2021:1161923. doi: 10.1155/2021/1161923. eCollection 2021.
2
Optimal control modulation of HIV reservoir formation rate by antigen infusion.通过抗原注入对HIV储存库形成率进行最优控制调节
Proc IEEE Conf Decis Control. 2019 Dec;2019:5662-5667. doi: 10.1109/cdc40024.2019.9028891. Epub 2020 Mar 12.

本文引用的文献

1
Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence.游离型 HIV-1 DNA 及其与 HIV-1 持续存在的其他标志物的关系。
Retrovirology. 2018 Jan 30;15(1):15. doi: 10.1186/s12977-018-0398-1.
2
Persistent HIV-1 replication during antiretroviral therapy.抗逆转录病毒治疗期间HIV-1的持续复制。
Curr Opin HIV AIDS. 2016 Jul;11(4):417-23. doi: 10.1097/COH.0000000000000287.
3
Failure of combined antiretroviral therapy intensification with maraviroc and raltegravir in chronically HIV-1 infected patients to reduce the viral reservoir: the IntensHIV randomized trial.慢性 HIV-1 感染患者联合强化抗逆转录病毒治疗(马拉维若和雷特格韦)未能降低病毒储存库:IntensHIV 随机试验。
AIDS Res Ther. 2014 Oct 7;11(1):33. doi: 10.1186/1742-6405-11-33. eCollection 2014.
4
Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues.持续性 HIV-1 复制与淋巴组织中抗逆转录病毒药物浓度降低有关。
Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):2307-12. doi: 10.1073/pnas.1318249111. Epub 2014 Jan 27.
5
Spatial modeling of HIV cryptic viremia and 2-LTR formation during raltegravir intensification.雷特格韦强化治疗期间HIV隐匿性病毒血症和2-LTR形成的空间建模
J Theor Biol. 2014 Mar 21;345:61-9. doi: 10.1016/j.jtbi.2013.12.020. Epub 2013 Dec 28.
6
Redefining the viral reservoirs that prevent HIV-1 eradication.重新定义阻止 HIV-1 根除的病毒储存库。
Immunity. 2012 Sep 21;37(3):377-88. doi: 10.1016/j.immuni.2012.08.010.
7
Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel.成人 HIV 感染的抗逆转录病毒治疗:美国国际抗病毒学会 2012 年推荐意见。
JAMA. 2012 Jul 25;308(4):387-402. doi: 10.1001/jama.2012.7961.
8
HIV model parameter estimates from interruption trial data including drug efficacy and reservoir dynamics.包含药物疗效和储存动力学的中断试验数据的 HIV 模型参数估计。
PLoS One. 2012;7(7):e40198. doi: 10.1371/journal.pone.0040198. Epub 2012 Jul 16.
9
No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapy.拉替拉韦强化治疗对接受抗逆转录病毒治疗的 HIV-1 感染患者血液中病毒复制标志物无影响。
J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):229-35. doi: 10.1097/QAI.0b013e31823fd1f2.
10
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects.整合酶抑制剂拉替拉韦强化治疗可影响 HIV-1 复制和免疫动力学。
Nat Med. 2010 Apr;16(4):460-5. doi: 10.1038/nm.2111. Epub 2010 Mar 14.